State-of-the-art liver disease research using liver-on-a-chip

Inflamm Regen. 2022 Dec 9;42(1):62. doi: 10.1186/s41232-022-00248-0.

Abstract

To understand disease pathophysiologies, models that recapitulate human functions are necessary. In vitro models that consist of human cells are preferred to ones using animal cells, because organ functions can vary from species to species. However, conventional in vitro models do not recapitulate human organ functions well. Organ-on-a-chip technology provides a reliable in vitro model of the functional units of human organs. Organ-on-a-chip technology uses microfluidic devices and their accessories to impart organ functions to human cells. Using microfluidic devices, we can co-culture multiple cell types that compose human organs. Moreover, we can culture human cells under physiologically relevant stresses, such as mechanical and shear stresses. Current organ-on-a-chip technology can reproduce the functions of several organs including the liver. Because it is difficult to maintain the function of human hepatocytes, which are the gold standard of in vitro liver models, under conventional culture conditions, the application of liver-on-a-chips to liver disease research is expected. This review introduces the current status and future prospects of liver-on-a-chips in liver disease research.

Keywords: Alcoholic liver diseases; Drug-induced liver injuries; Hepatic zonation; Infectious liver diseases; Liver-on-a-chip; NAFLD/NASH; Organ-on-a-chip.

Publication types

  • Review